A Canadian researcher has won a 2025 Breakthrough Prize in Life Sciences for discovering the GLP-1 hormone used in diabetes ...

The Centers for Medicare Medicaid Services (CMS) announced it will not proceed with a Biden administration proposal to expand ...

That's why Veeva Systems should remain a leader in its niche and deliver excellent returns over the long run. It's a top stock to buy and hold for the next two decades.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Arrowstreet Capital Limited Partnership decreased its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 99.1% during the 4th quarter, according to the company in its most recent filing ...

UnitedHealth Group, Eli Lilly and Company, and Walmart are the three Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks are shares in companies that provide ...

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...

Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.

Diabetes patients on dulaglutide (Trulicity) had better glycemic control and more weight loss if they switched to tirzepatide ...

The study finds better A1c lowering and weight reduction, but an expert clinician says practical issues may pose barriers.

Jim Cramer in a latest program on CNBC urged investors to start accepting the reality of the new economic system under ...

Novo Nordisk is licensing a drug called LX9851 from Lexicon Pharmaceuticals for up to $75 million in upfront and near-term ...